Leaders in Research Peptides

(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD
(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD
Highest Quality | For Research Use Only

CJC-1295 DAC

Buy CJC-1295 DAC Estonia Peptide

CJC-1295 is a synthetic growth hormone known as a GHRH. It is made up of 30 amino acids and belongs to a group of peptides called IGF1.

Research indicates that CJC-1295 can increase levels of growth hormone, leading to various benefits. These include improved muscle growth, enhanced fat metabolism, and better sleep quality. It has also been shown to assist with weight management and boost the metabolism.

Additionally, studies suggest that CJC-1295 may have potential benefits for tissue repair and immune function. For example, a study published in the “Journal of Clinical Endocrinology & Metabolism” found that CJC-1295 can promote collagen production, potentially aiding in wound healing and promoting healthy skin.

Showing all 9 results

Potential Benefits of CJC-1295 DAC Peptide

  • Increased Muscle Growth: CJC-1295 DAC stimulates the release of growth hormone, which plays a vital role in muscle growth and strength. This can potentially help in increasing lean muscle mass and improving physical performance [1].
  • Fat Loss: Studies suggest that CJC-1295 DAC may help reduce body fat. It does this by promoting lipolysis, the process where the body breaks down fats to use as energy [2].
  • Improved Sleep: As an analogue of growth hormone-releasing hormone (GHRH), research has indicated that CJC-1295 DAC may improve sleep patterns by influencing the sleep-wake cycle [3].
  • Enhanced Skin Health: Scientific studies suggest that by stimulating the production of growth hormone, CJC-1295 DAC may promote healthier skin. Growth hormone is known to play a role in cell regeneration and repair, which can lead to improved skin elasticity and reduced wrinkles [4].
  • Increased Bone Density: Growth hormone also plays a role in bone health. By stimulating its production, CJC-1295 DAC studies indicate it may help increase bone density, reducing the risk of fractures and osteoporosis [2].
  • Longer Half-Life: According to research, with the Drug Affinity Complex (DAC), CJC-1295 has a longer half-life than other peptides, meaning its effects last longer in the body [5].
  • Promotion of Protein Synthesis: Research suggests CJC-1295 DAC can promote protein synthesis, a crucial process for muscle growth and recovery [5].

References:

[1] https://pubmed.ncbi.nlm.nih.gov/17132735/

[2] https://academic.oup.com/jcem/ article/91/12/4792/2656274

[3] https://www.researchgate.net/ publication/290598043

[4] https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC2699641/

[5] https://pubmed.ncbi.nlm.nih.gov/16352683/

 

ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Direct Peptides website: https://estonia.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.